Q32 Bio Inc. (QTTB)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Provision for income taxes | - | - | - | |
| Loss from equity method investment | - | - | - | |
| Research and development | 5,161 | 7,124 | 14,346 | |
| General and administrative | 4,010 | 5,104 | 4,468 | |
| Total operating expenses | 9,171 | 12,228 | 18,814 | |
| Loss from operations | -9,171 | -12,228 | -18,814 | |
| Other income (expense), net | -318 | 1,197 | 1,219 | |
| Change in fair value of convertible notes | - | - | - | |
| Total other income (expense), net | -318 | 1,197 | 1,219 | |
| Loss before provision for income taxes and loss from equity method investment | -9,489 | -11,031 | -17,595 | |
| Net loss | -9,489 | -11,031 | -17,595 | |
| Net loss per share - basic | -0.78 | -0.9 | -1.46 | |
| Net loss per share - diluted | -0.78 | -0.9 | -1.46 | |
| Weighted average number of shares outstanding, basic | 12,197,615 | 12,197,615 | 12,076,412 | |
| Weighted average number of shares outstanding, diluted | 12,197,615 | 12,197,615 | 12,076,412 | |